Core Scientific, Inc.
CORZ · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $510,672 | $502,400 | $640,313 | $544,483 |
| % Growth | 1.6% | -21.5% | 17.6% | – |
| Cost of Goods Sold | $389,602 | $378,941 | $631,913 | $305,621 |
| Gross Profit | $121,070 | $123,459 | $8,400 | $238,862 |
| % Margin | 23.7% | 24.6% | 1.3% | 43.9% |
| R&D Expenses | $11,830 | $7,184 | $26,962 | $7,674 |
| G&A Expenses | $110,448 | $93,908 | $213,280 | $0 |
| SG&A Expenses | $120,417 | $100,927 | $226,011 | $64,548 |
| Sales & Mktg Exp. | $9,969 | $7,019 | $12,731 | $0 |
| Other Operating Expenses | $8,019 | $6,387 | $1,864,980 | $0 |
| Operating Expenses | $140,266 | $114,498 | $2,117,953 | $72,222 |
| Operating Income | -$19,196 | $8,961 | -$2,109,553 | $166,640 |
| % Margin | -3.8% | 1.8% | -329.5% | 30.6% |
| Other Income/Exp. Net | -$1,294,950 | -$254,765 | -$53,856 | -$103,565 |
| Pre-Tax Income | -$1,314,146 | -$245,804 | -$2,163,409 | $63,075 |
| Tax Expense | $859 | $683 | -$17,091 | $15,763 |
| Net Income | -$1,315,005 | -$246,487 | -$2,146,318 | $47,312 |
| % Margin | -257.5% | -49.1% | -335.2% | 8.7% |
| EPS | -5.14 | -0.65 | -6.3 | 0.23 |
| % Growth | -690.8% | 89.7% | -2,839.1% | – |
| EPS Diluted | -5.14 | -0.65 | -6.3 | 0.2 |
| Weighted Avg Shares Out | 255,832 | 379,863 | 340,647 | 207,263 |
| Weighted Avg Shares Out Dil | 255,832 | 379,863 | 340,647 | 233,305 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $37,070 | $86,238 | $96,826 | $44,354 |
| Depreciation & Amortization | $120,121 | $96,445 | $226,093 | $33,362 |
| EBITDA | -$1,156,955 | -$63,121 | -$1,840,490 | $140,791 |
| % Margin | -226.6% | -12.6% | -287.4% | 25.9% |